MedPage Today on MSN17h
The FDA Hasn't Inspected This Drug Factory After 7 Recalls for the Same Flaw
Since the May recall, Glenmark told regulators it has received reports of three deaths, three hospitalizations, and four ...
What is Red 40 and why hasn't the FDA banned the dye?
The FDA's top food official says the safety of the dye called Red 40 hasn't been assessed in over a decade, despite concerns ...
FDA recall: More than 233,000 bottles of antidepressant could contain cancerous chemical
The more than 233,000 bottles of duloxetine contain the "presence" of nitrosamine drug substance impurity, ...
Newsweek on MSN2d
Antidepressant Recall Update As FDA Sets Risk Level
233,003 bottles of duloxetine have been recalled due to potentially containing high levels of cancer-causing impurities.
Food Safety News4h
FDA issues warning letters over allergen labeling failures and sanitation concerns
As part of its enforcement activities, the Food and Drug Administration sends warning letters to entities under its jurisdiction. Some letters are not ...
What is duloxetine and how does it work? What to know about antidepressant recalled by FDA
An SNRI (serotonin and norepinephrine reuptake inhibitor) is one of two major classes of medications used to treat clinical ...
US FDA approves Checkpoint's skin cancer drug
The U.S Food and Drug Administration said on Friday it has approved Checkpoint Therapeutics' drug for treatment of a type of ...
Medscape14h
Nemolizumab Gets FDA Nod for Atopic Dermatitis
The US Food and Drug Administration (FDA) has approved nemolizumab for moderate-to-severe atopic dermatitis inadequately ...
Health Affairs2d
Will The New Administration’s FDA Be A Threat Or An Opportunity For The Public's Health?
The immediate aftermath of the 2024 presidential election has brought renewed attention to regulatory policy at the U.S. Food ...
US FDA approves Neurocrine Biosciences' genetic disorder drug
The U.S. Food and Drug Administration has approved Neurocrine Biosciences' drug to treat a type of genetic disorder, the ...